Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Ironwood Pharmaceuticals. A complete text table follows the diagram.
Gastrointestinal medicines, royalties, and partnered products support patients with digestive disease.
Swipe to explore
The operating total is tied to the downloaded filing; the destination is an editorial label for the disclosed business engine, with no invented segment allocation.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Reported operating total | 1 | $140M | Directly reported in the downloaded 10-Q |
| Gastrointestinal-medicine platform | 2 | $140M | Gastrointestinal medicines, royalties, and partnered products support patients with digestive disease. |
| From | To | Value |
|---|---|---|
| Reported operating total | Gastrointestinal-medicine platform | $140M |